Migraine Among Sohag University Students

NCT ID: NCT06536920

Last Updated: 2024-08-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-01

Study Completion Date

2025-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Diagnosis of migraine among students and detect frequency among them and detect how far migraine affect their life

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Migraine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sohag university students

Who diagnosed as migraine among sohag university students

Migraine screening questionnaire

Intervention Type DIAGNOSTIC_TEST

Screening test

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Migraine screening questionnaire

Screening test

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age from 18 to 25 years old.
* students accept to give informed consent

Exclusion Criteria

* Students refused to give informed consent
* Age less than 18 or more than 25 ears old.
Minimum Eligible Age

18 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed ElSayed Sadek

Principle investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sohag university hospital

Sohag, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed Elsayed Sedek

Role: CONTACT

01122816728

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ahmed Elsayed Sedek

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-24-05-03MS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Migraine in Adolescents
NCT05654012 RECRUITING NA
Zonisamide Versus Topiramate in Migraine
NCT06347497 RECRUITING PHASE3
Education on Migraine in Pregnant Women
NCT06054399 NOT_YET_RECRUITING NA
Valproate Versus Topiramate in Migraine
NCT06248931 COMPLETED PHASE3